Related Experiment Video
Updated: May 18, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Considerations on Auditing and GxP Requirements along the Product Lifecycle
Stephan Rönninger1, Siegfried Schmitt, Vijaya Rangavajhula
1F. Hoffmann-La Roche Ltd.
PDA Journal of Pharmaceutical Science and Technology
|October 5, 2012
Summary
Global pharmaceutical manufacturers must adhere to current Good Practices (GxP) standards for regulatory compliance. This involves auditing against laws and considering the entire product lifecycle from development to commercialization.
Area of Science:
- Pharmaceutical Manufacturing
- Regulatory Compliance
- Quality Management Systems
Background:
- Global pharmaceutical manufacturing requires adherence to stringent regulatory standards.
- Ensuring compliance across diverse international markets presents significant challenges.
- The Paradigm Change for Manufacturing Operations (PCMO) initiative addresses evolving manufacturing paradigms.
Purpose of the Study:
- To summarize current Good Practices (GxP) standards for global pharmaceutical manufacturers.
- To outline the requirements for achieving compliance with international regulatory bodies.
- To emphasize the importance of lifecycle management in pharmaceutical production.
Main Methods:
- Review of current GxP guidelines and regulatory expectations.
- Analysis of global, regional, and domestic legal frameworks.
- Focus on auditing processes throughout the product lifecycle.
Main Results:
- Identification of key GxP standards applicable to global pharmaceutical operations.
- Emphasis on the integration of lifecycle management in compliance strategies.
- Highlighting the role of risk-based auditing in maintaining standards.
Conclusions:
- Adherence to comprehensive GxP standards is critical for global pharmaceutical compliance.
- A holistic approach, encompassing product lifecycle and regulatory landscapes, is essential.
- Risk-based auditing is a key component for sustained manufacturing quality and compliance.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:05Quality Control
Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
01:19Quality Assurance
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...